EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 3.0

Soluble CD40 ligand, interleukin (IL)-6, and hemostatic parameters in metabolic syndrome patients with and without overt ischemic heart disease

Nader El-Shahhat, Mahmoud M. Ramadan, Nader El-Malkey, Ashraf A. Omar, Ibrahim A. Abd El-Aal, Asmaa Eneen

The Egyptian Heart Journal · 2011

DOI: 10.1016/j.ehj.2011.08.024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Egyptian Heart Journal, 2011. Verfasst von Nader El-Shahhat und 5 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

El-Shahhat, N., Ramadan, M. M., El-Malkey, N., Omar, A. A., El-Aal, I. A. A., & Eneen, A. (2011). Soluble CD40 ligand, interleukin (IL)-6, and hemostatic parameters in metabolic syndrome patients with and without overt ischemic heart disease. The Egyptian Heart Journal. https://doi.org/10.1016/j.ehj.2011.08.024

Vancouver

El-Shahhat N, Ramadan MM, El-Malkey N, Omar AA, El-Aal IAA, Eneen A. Soluble CD40 ligand, interleukin (IL)-6, and hemostatic parameters in metabolic syndrome patients with and without overt ischemic heart disease. The Egyptian Heart Journal. 2011. doi:10.1016/j.ehj.2011.08.024

BibTeX
@article{ElShahhat2011,
  author = {El-Shahhat, Nader and Ramadan, Mahmoud M. and El-Malkey, Nader and Omar, Ashraf A. and El-Aal, Ibrahim A. Abd and Eneen, Asmaa},
  title = {Soluble CD40 ligand, interleukin (IL)-6, and hemostatic parameters in metabolic syndrome patients with and without overt ischemic heart disease},
  journal = {The Egyptian Heart Journal},
  year = {2011},
  doi = {10.1016/j.ehj.2011.08.024}
}
Kostenlos starten →